Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis

医学 血压 内科学 危险系数 随机对照试验 荟萃分析 临床试验 疾病 心脏病学 置信区间
作者
Joshua D. Bundy,Changwei Li,Patrick M. Stuchlik,Xiaoqing Bu,Tanika N. Kelly,Katherine T. Mills,Hua He,Jing Chen,Paul Kieran Whelton,Jiang He
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:2 (7): 775-775 被引量:892
标识
DOI:10.1001/jamacardio.2017.1421
摘要

Importance: Clinical trials have documented that lowering blood pressure reduces cardiovascular disease and premature deaths. However, the optimal target for reduction of systolic blood pressure (SBP) is uncertain. Objective: To assess the association of mean achieved SBP levels with the risk of cardiovascular disease and all-cause mortality in adults with hypertension treated with antihypertensive therapy. Data Sources: MEDLINE and EMBASE were searched from inception to December 15, 2015, supplemented by manual searches of the bibliographies of retrieved articles. Study Selection: Studies included were clinical trials with random allocation to an antihypertensive medication, control, or treatment target. Studies had to have reported a difference in mean achieved SBP of 5 mm Hg or more between comparison groups. Data Extraction and Synthesis: Data were extracted from each study independently and in duplicate by at least 2 investigators according to a standardized protocol. Network meta-analysis was used to obtain pooled randomized results comparing the association of each 5-mm Hg SBP category with clinical outcomes after adjusting for baseline risk. Main Outcomes and Measures: Cardiovascular disease and all-cause mortality. Results: Forty-two trials, including 144 220 patients, met the eligibility criteria. In general, there were linear associations between mean achieved SBP and risk of cardiovascular disease and mortality, with the lowest risk at 120 to 124 mm Hg. Randomized groups with a mean achieved SBP of 120 to 124 mm Hg had a hazard ratio (HR) for major cardiovascular disease of 0.71 (95% CI, 0.60-0.83) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.58 (95% CI, 0.48-0.72) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.46 (95% CI, 0.34-0.63) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.36 (95% CI, 0.26-0.51) compared with those with a mean achieved SBP of 160 mm Hg or more. Likewise, randomized groups with a mean achieved SBP of 120 to 124 mm Hg had an HR for all-cause mortality of 0.73 (95% CI, 0.58-0.93) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.59 (95% CI, 0.45-0.77) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.51 (95% CI, 0.36-0.71) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.47 (95% CI, 0.32-0.67) compared with those with a mean achieved SBP of 160 mm Hg or more. Conclusions and Relevance: This study suggests that reducing SBP to levels below currently recommended targets significantly reduces the risk of cardiovascular disease and all-cause mortality. These findings support more intensive control of SBP among adults with hypertension.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
清辉影的应助被漫漫采纳,获得10
1秒前
2秒前
等风归发布了新的文献求助10
3秒前
4秒前
昏睡的绿海完成签到,获得积分10
4秒前
AKKK完成签到 ,获得积分10
4秒前
4秒前
逆流沙完成签到,获得积分10
5秒前
FashionBoy的应助被马亚斌采纳,获得10
5秒前
839788336完成签到,获得积分10
6秒前
归帆发布了新的文献求助10
6秒前
iNk的应助被ladywerwer采纳,获得10
7秒前
NUS完成签到,获得积分10
7秒前
gentle发布了新的文献求助10
7秒前
wspqbs关注了科研通微信公众号
8秒前
xiang完成签到,获得积分10
9秒前
erlangenbio完成签到,获得积分10
9秒前
9秒前
深情安青的应助被杜欣悦采纳,获得10
10秒前
11秒前
modoun完成签到,获得积分10
12秒前
iNk的应助被ladywerwer采纳,获得10
13秒前
apricity199的应助被淘宝叮咚采纳,获得10
14秒前
吃不饱完成签到 ,获得积分10
15秒前
空城完成签到 ,获得积分20
17秒前
17秒前
ladywerwer完成签到,获得积分10
18秒前
18秒前
18秒前
wspqbs发布了新的文献求助30
20秒前
20秒前
风中巧凡完成签到,获得积分10
21秒前
bqys发布了新的文献求助10
21秒前
jean完成签到,获得积分10
22秒前
哇啦发布了新的文献求助10
22秒前
23秒前
研友_VZG7GZ的应助被O基米德采纳,获得10
23秒前
笑点低薯片完成签到,获得积分10
26秒前
小马甲的应助被调皮钧采纳,获得10
26秒前
雅2018完成签到 ,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621